LEBOEUF RAYMOND W 4
4 · PRAXAIR INC · Filed Nov 8, 2017
Insider Transaction Report
Form 4
LEBOEUF RAYMOND W
Director
Transactions
- Sale
Common Stock
2016-11-07$117.26/sh−6,550$768,073→ 10,147.368 total - Exercise/Conversion
Stock Option (right to buy)
2016-11-07−6,550→ 0 totalExercise: $61.47From: 2008-02-27Exp: 2017-02-27→ Common Stock (6,550 underlying) - Exercise/Conversion
Common Stock
2016-11-07$61.47/sh+6,550$402,629→ 16,697.368 total
Holdings
- 4,600
Stock Option (right to buy)
Exercise: $60.92From: 2010-02-24Exp: 2019-02-24→ Common Stock (4,600 underlying) - 48,565.813
Deferred Stock
Exercise: $0.00→ Common Stock (48,565.813 underlying) - 3,885
Stock Option (right to buy)
Exercise: $83.89From: 2009-02-26Exp: 2018-02-26→ Common Stock (3,885 underlying)
Footnotes (4)
- [F1]The $117.263 price reported is the weighted average sale price. The sale prices ranged from $117.258 to $117.288 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F2]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
- [F3]Conversion to Praxair Common Stock is on a 1-for-1 basis.
- [F4]Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service.